Methylcobalamin is one of the two biologically active forms of B12, meaning it doesnt require conversion before the body can use it
DOI: 10.1038/s41467-017-01114-1 Formulation strategies for therapeutic peptide stability pH, ionic strength, co-solvency
It's one of the first questions patients ask their providers, and honestly, it's the right question to ask
The initial findings were so impressive that some researchers suggested BPC-157 could be the prototype of a new class of organoprotective agents. There were still many unanswered questions, though: Would other studies replicate these findings
In addition, people who take a vitamin B12 overdose, especially in parenteral form, may be affected by reversible skin reactions
So will be interested in others views research